SelSym Biotech

StageSeed

Raised$4.73M

Founded2019

Employees6

LocationRaleigh, NC

About

SelSym Biotech is a preclinical stage biotechnology startup located in North Carolina's Research Triangle developing novel platelet-mimetic therapeutics for the treatment of uncontrolled bleeding.

Product

Value proposition: Hemostatic Healing Hydrogel platform and lead product SymClot that mimic platelet functions to rapidly control bleeding and promote wound healing, enabling rapid multi-patient response with minimal waste

Founders

Seema Nandi — CEO, Co-Founder, and Chair of the Board
Ashley Brown — Co-Founder, Senior Scientific Advisor, and Director
L. Andrew Lyon — President, Co-Founder, and Director
Tom Barker — Co-Founder, Senior Scientific Advisor, and Director

Products

SymClotHemostatic Healing Hydrogel platformplatelet-mimetic technology suite

Key features

rapid bleeding controlplatelet-mimetic mechanismuniversally compatiblesynthetic design (no blood typing)shelf-stablereconstitute and inject on-demandhighly tunable for wide range of clinical needs

Technologies

synthetic hydrogelplatelet-mimetic technologyhemostasistissue regeneration

Target conditions

traumatic injurypost-surgical bleedingwound caretissue regeneration

Care settings

roadsideoperating roomclinical settingsemergency/traumahospital

News

Saving Lives in the Critical Minutes: How SelSym Biotech is Transforming Trauma Care | College of Engineering · 2026-02-20T19:51:18.000Z
Saving Lives in the Critical Minutes: How SelSym Biotech is Transforming Trauma Care | Innovation and Entrepreneurship · 2026-02-12T17:07:48.000Z
Synthetic Blood Platelets Might Be as Good as the Real Thing to Stop Bleeding - Research - Medicine in Motion News · 2024-09-04T07:00:14.000Z
Meet the Venture Connect 2026 Company Lineup · 2026-02-25T00:00:00.000Z
SelSym Biotech Innovates Trauma Care with Hemostatic Healing... · 2026-03-19T00:00:00.000Z
Andrew Lyon - Professor | Co-Founder & President, SelSym Biotech... · 2025-12-06T00:00:00.000Z